No Data
No Data
BridgeBio Pharma Independent Director Wen-Chaun Lo Sells 39% Of Holding
BridgeBio to Participate in the Bank of America Merrill Lynch Global Healthcare Conference 2025
Major Insider Sales Shake Up BridgeBio Pharma Stock!
Bridgebio Pharma Insider Sold Shares Worth $3,849,900, According to a Recent SEC Filing
BridgeBio Pharma(BBIO.US) Director Sells US$3.85 Million in Common Stock
New Analyst Forecast: $BBIO Given $72.0 Price Target